Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$11.39 - $22.17 $15,046 - $29,286
1,321 New
1,321 $24.3 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $193M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Raiffeisen Bank International Ag Portfolio

Follow Raiffeisen Bank International Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raiffeisen Bank International Ag, based on Form 13F filings with the SEC.

News

Stay updated on Raiffeisen Bank International Ag with notifications on news.